Bernstein cuts Hershey stock price target on muted Q2 outlook

Hershey reported Q1 2026 EPS of $2.35 versus $2.04 expected and revenue of $3.1 billion versus $3.02 billion, a modest beat. Management reiterated full-year guidance, expects gross margin expansion of about 300 bps next quarter and 500 bps in the back half, but warned Q2 organic sales growth could slow to flattish with confectionery slightly negative. Analysts remain mixed, with Bernstein cutting its price target to $208 while TD Cowen raised its target to $210 and Barclays trimmed to $220.

Analysis

HSY is signaling a margin-led earnings inflection, but the market is likely underestimating how much of the near-term upside is being pulled forward into the back half. If gross margin expansion is really concentrated later in the year, the first catalyst is multiple expansion on confidence rather than immediate EPS revision, which tends to support the stock for 1-2 quarters even if volumes stay soft. That creates a setup where the tape can grind higher before the real operating proof arrives.

The more interesting second-order effect is on category economics: a premium launch plus better shelf space in multiple channels suggests Hershey is using pricing architecture and distribution density to defend mix even as unit growth remains pressured. That is usually a warning sign for smaller confection competitors and private label, because shelf resets often lock in disproportionate facings before demand fully shows up. If that shelf gain sticks, the benefit should compound into 2026 through higher productivity per store rather than just a one-off holiday uplift.

Consensus may be too anchored to the muted second quarter and too dismissive of management’s ability to re-accelerate guidance later in the year. The real risk is that the margin bridge depends on international shipment timing, which can reverse quickly if retailer inventory normalizes or if competitive merchandising remains aggressive. On a 3-6 month horizon, this is less about whether the quarter is good and more about whether the market starts paying up for a cleaner H2 trajectory.

The contrarian angle is that the current setup may actually be better for holders than for new shorts: downside looks limited unless organic sales re-decelerate meaningfully, while the bar for a modestly positive guidance raise is not high. However, if the stock already prices in a 2026 volume recovery too early, the cleanest way to fade enthusiasm is through time decay rather than outright equity shorting.

Key Decisions for Investors

• Go long HSY on pullbacks over the next 1-2 weeks; target a 5-8% move over 3 months if H2 margin expansion remains intact, with a stop if next quarter organic sales turn decisively negative.
• Sell downside protection via put spreads in HSY for the next earnings cycle; implied volatility should remain supported, and the asymmetry favors collecting premium while the stock grinds on guidance credibility.
• Pair trade: long HSY / short a smaller confection or snack competitor over 3-6 months to express shelf-space and mix advantage; the edge is strongest if channel resets persist and volume remains scarce.
• Avoid chasing the stock after strong days; wait for post-earnings or market-wide risk-off dips, since the near-term catalyst is guidance revision rather than immediate top-line acceleration.
• If management confirms a 2026 guide raise, add to HSY only on the first pullback after the print; the better trade is to own the rerating before consensus fully bakes in H2 margin leverage.